Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-EN Version v6-FR
Language English French
Date Updated 2019-07-30 2019-05-22
Drug Identification Number 02423421 02423421
Brand name MYLAN-RIVASTIGMINE PATCH 10 MYLAN-RIVASTIGMINE PATCH 10
Common or Proper name RIVASTIGMINE RIVASTIGMINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients RIVASTIGMINE RIVASTIGMINE
Strength(s) 18MG 18MG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 30 PATCHES 30 PATCHES
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-06-04 2019-06-05
Actual start date 2019-06-04
Estimated end date 2019-07-26 2019-06-15
Actual end date 2019-07-29
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments